Literature DB >> 20411769

Basal ganglia control of substantia nigra dopaminergic neurons.

Christian R Lee1, James M Tepper.   

Abstract

Although substantia nigra dopaminergic neurons are spontaneously active both in vivo and in vitro, this activity does not depend on afferent input as these neurons express an endogenous calcium-dependent oscillatory mechanism sufficient to drive action potential generation. However, afferents to these neurons, a large proportion of them GABAergic and arising from other nuclei in the basal ganglia, play a crucial role in modulating the activity of dopaminergic neurons. In the absence of afferent activity or when in brain slices, dopaminergic neurons fire in a very regular, pacemaker-like mode. Phasic activity in GABAergic, glutamatergic, and cholinergic inputs modulates the pacemaker activity into two other modes. The most common is a random firing pattern in which interspike intervals assume a Poisson-like distribution, and a less common pattern, often in response to a conditioned stimulus or a reward in which the neurons fire bursts of 2-8 spikes time-locked to the stimulus. Typically in vivo, all three firing patterns are observed, intermixed, in single nigrostriatal neurons varying over time. Although the precise mechanism(s) underlying the burst are currently the focus of intensive study, it is obvious that bursting must be triggered by afferent inputs. Most of the afferents to substantia nigra pars compacta dopaminergic neurons comprise monosynaptic inputs from GABAergic projection neurons in the ipsilateral neostriatum, the globus pallidus, and the substantia nigra pars reticulata. A smaller fraction of the basal ganglia inputs, something less than 30%, are glutamatergic and arise principally from the ipsilateral subthalamic nucleus and pedunculopontine nucleus. The pedunculopontine nucleus also sends a cholinergic input to nigral dopaminergic neurons. The GABAergic pars reticulata projection neurons also receive inputs from all of these sources, in some cases relaying them disynaptically to the dopaminergic neurons, thereby playing a particularly significant role in setting and/or modulating the firing pattern of the nigrostriatal neurons.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20411769     DOI: 10.1007/978-3-211-92660-4_6

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  23 in total

Review 1.  α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease.

Authors:  Maryka Quik; Susan Wonnacott
Journal:  Pharmacol Rev       Date:  2011-12       Impact factor: 25.468

Review 2.  Intrinsic and integrative properties of substantia nigra pars reticulata neurons.

Authors:  F-M Zhou; C R Lee
Journal:  Neuroscience       Date:  2011-08-02       Impact factor: 3.590

3.  Upper brainstem GABA levels in Parkinson's disease.

Authors:  Yulu Song; Tao Gong; Muhammad G Saleh; Mark Mikkelsen; Guangbin Wang; Richard A E Edden
Journal:  MAGMA       Date:  2021-03-20       Impact factor: 2.310

Review 4.  H2O2: a dynamic neuromodulator.

Authors:  Margaret E Rice
Journal:  Neuroscientist       Date:  2011-06-10       Impact factor: 7.519

Review 5.  Dopaminergic Neurons and Brain Reward Pathways: From Neurogenesis to Circuit Assembly.

Authors:  Sarah X Luo; Eric J Huang
Journal:  Am J Pathol       Date:  2015-12-24       Impact factor: 4.307

6.  Relationships between Pupil Diameter and Neuronal Activity in the Locus Coeruleus, Colliculi, and Cingulate Cortex.

Authors:  Siddhartha Joshi; Yin Li; Rishi M Kalwani; Joshua I Gold
Journal:  Neuron       Date:  2015-12-17       Impact factor: 17.173

7.  Modulation of in vivo GABA-evoked responses by nitric oxide-active compounds in the globus pallidus of rat.

Authors:  Fabio Carletti; Giuseppe Ferraro; Valerio Rizzo; Simonetta Friscia; Pierangelo Sardo
Journal:  J Neural Transm (Vienna)       Date:  2012-01-19       Impact factor: 3.575

Review 8.  Neurophysiology of the brain stem in Parkinson's disease.

Authors:  Cecilia Bove; R Alberto Travagli
Journal:  J Neurophysiol       Date:  2019-03-27       Impact factor: 2.714

9.  Vulnerability of mesostriatal dopaminergic neurons in Parkinson's disease.

Authors:  Tomás González-Hernández; Ignacio Cruz-Muros; Domingo Afonso-Oramas; Josmar Salas-Hernandez; Javier Castro-Hernandez
Journal:  Front Neuroanat       Date:  2010-10-20       Impact factor: 3.856

10.  Immunocytochemical identification of proteins involved in dopamine release from the somatodendritic compartment of nigral dopaminergic neurons.

Authors:  P Witkovsky; J C Patel; C R Lee; M E Rice
Journal:  Neuroscience       Date:  2009-08-12       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.